International surveys find HPV‐negativity in up to 30% of cervical adenocarcinomas. We
investigated the pathological diagnosis by expert consensus with immunohistochemistry …

OBJECTIVE: To review and characterise by clinical evaluation, immunohistochemistry and
HPV typing a group of adenocarcinomas initially diagnosed with primary localisation in the …

Objective Using highly sensitive polymerase chain reaction (PCR) techniques, we
reanalysed all cervical carcinomas (CC s) found to be human papillomavirus (HPV) …

Simple Summary Although cervical cancer is mainly caused by infection with human
papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative …

Human papillomaviruses (HPV) are the causative agents of virtually all cervical carcinomas.
Nevertheless, a small proportion of cervical cancer are negative for HPV, although the …

Adenocarcinoma in situ (ACIS) and adenocarcinoma (AdCA) of the cervix are frequently
missed in population‐based screening programmes. Adding high‐risk HPV (hrHPV) testing …

We investigated HPV in adenocarcinoma presenting and managed as cervical
adenocarcinoma (CADC) at seven major representative regional cancer centres across …

Objective We examined a large series of biopsy-proven invasive cervical cancers with
surgical staging and HPV re-testing to estimate the relevance of HPV-negative cervical …

Human Papillomavirus (HPV) is reported in 60–100% of cervical adenocarcinoma (CADC)
globally. We investigated this relationship in a hospital‐based survey in China. 718 CADC …

Objectives. Infection with the high-risk strain of human papillomaviruses (HPVs) and the
inactivation of the tumor suppressor genep53through mutation are important factors in …